Pediatrix Medical (MD) Net Income towards Common Stockholders (2009 - 2026)

Pediatrix Medical has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting $29.6 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 42.61% year-over-year to $29.6 million; the TTM figure through Mar 2026 stood at $183.8 million (up 317.47% YoY), while the FY2025 annual figure was $175.0 million, changed N/A from the prior year.
• Net Income towards Common Stockholders declined to $29.6 million in Q1 2026, from $43.3 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for MD reached as high as $71.7 million in Q3 2025 and fell as low as -$153.0 million in Q2 2024.
• The 4-year median for Net Income towards Common Stockholders is $19.4 million (2024), against an average of $8.2 million.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 179.61% — and 2025, when it surged 413.93%.
• A 4-year view of Net Income towards Common Stockholders shows it stood at $5.7 million in 2022, then surged by 400.34% to $28.3 million in 2024, then surged by 52.91% to $43.3 million in 2025, then sank by 31.7% to $29.6 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $29.6 million, $43.3 million, and $71.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.